Democratic Sens. Adam Schiff and Mazie Hirono face online criticism after making a comparison between a military testosterone-screening initiative attributed to Pete Hegseth and “gender-affirming care,” according to reports. Both outlets describe backlash aimed at the lawmakers for framing the proposed testosterone program in language associated with gender-affirming medical services. The criticism centers on the appropriateness of the comparison rather than on a specific clinical outcome, with commenters arguing the policy domains are different.
The outlets agree that the remarks circulated widely online and led to prominent reactions. They also note that the issue is being discussed in the context of broader debates about health policy, military readiness, and how lawmakers discuss medical interventions. The coverage does not identify a consensus among medical experts in the reports provided, nor does it detail the specific policy design of any testosterone screening proposal. Overall, the reporting focuses on the political and public response to the analogy rather than on new evidence about the initiative’s effects.
